NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
Amber SPAAlpha Tocopheryl Acetate 500mg /5mL
(Suspension) 		Nutrition and blood, Vitamin E, 09.06.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Acarbose Acarbose Endocrine System, Blood Glucose Lowering Drugs, Alpha Glucosidase Inhibitors
Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus
Adalimumab Adalimumab Eye, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Allergic And Inflammatory Eye Conditions, Inflammatory Eye Conditions
Adalimumab Adalimumab Gastro-Intestinal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Chronic Bowel Disorders, Inflammatory Bowel Disease
Adalimumab Adalimumab Musculoskeletal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Arthritis
Adalimumab Adalimumab Skin, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Inflammatory Skin Conditions, Eczema And Psoriasis
Adalimumab Adalimumab Skin, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Inflammatory Skin Conditions, Hidradenitis Suppurativa
Alfacalcidol Alfacalcidol Nutrition And Metabolic Disorders, Vitamins And Trace Elements, Vitamin D And Analogues
Vitamin Deficiency
Alpha  Alpha Tocopherol Nutrition And Metabolic Disorders, Vitamins And Trace Elements, Vitamin E
Vitamin Deficiency
Alpha  Alpha Tocopheryl Acetate Nutrition And Metabolic Disorders, Vitamins And Trace Elements, Vitamin E
Vitamin Deficiency
Certolizumab  Certolizumab Pegol Musculoskeletal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Arthritis
Certolizumab  Certolizumab Pegol Skin, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Inflammatory Skin Conditions, Eczema And Psoriasis
Etanercept Etanercept Musculoskeletal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Arthritis
Etanercept Etanercept Skin, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Inflammatory Skin Conditions, Eczema And Psoriasis
FelodipineFelodipine Cardiovascular System, Calcium-Channel Blockers
Blood Pressure Conditions, Hypertension
FelodipineFelodipine Cardiovascular System, Calcium-Channel Blockers
Myocardial Ischaemia
Golimumab Golimumab Gastro-Intestinal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Chronic Bowel Disorders, Inflammatory Bowel Disease
Golimumab Golimumab Musculoskeletal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Arthritis
Infliximab Infliximab Gastro-Intestinal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Chronic Bowel Disorders, Inflammatory Bowel Disease
Infliximab Infliximab Musculoskeletal System, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Arthritis
Infliximab Infliximab Skin, Immunosuppressants, Tumor Necrosis Factor Alpha (TNF-A) Inhibitors
Inflammatory Skin Conditions, Eczema And Psoriasis
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
MHRA Drug Safety Update (April 2014) - Tumour necrosis factor alpha inhibitors
MHRA Drug Safety Update (April 2014) - Tumour necrosis factor alpha inhibitors
NICE TA383: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
NICE TA383: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
NICE TA407: Secukinumab for active ankylosing spondylitis after treatment with NSAIDs or TNF-alpha inhibitors